PCR Tests and COVID Vaccines are Useless
John French Sloan McSorley’s Bar 1912
If you’re enthusiastic about the impact of the newly arriving COVID vaccines, and you expect to “go back to normal” soon, don’t. You’re being fed fairy tales and other narratives. I won’t talk too much here, my quotes are plenty long enough as is.
After first reading an absolute decomposition of the PCR tests this morning, I figured out that the new vaccines being rolled out are equally useless. One has to wonder what goes on here. Just a few days ago, I quoted an article about a Portuguese court saying the PCR tests are 97% unreliable:
Landmark Legal Ruling Finds That Covid PCR Tests Are Not Fit For Purpose
This is not the first challenge to the credibility of PCR tests. Many people will be aware that their results have a lot to do with the number of amplifications that are performed, or the ‘cycle threshold.’ This number in most American and European labs is 35–40 cycles, but experts have claimed that even 35 cycles is far too many, and that a more reasonable protocol would call for 25–30 cycles. (Each cycle exponentially increases the amount of viral DNA in the sample).
[..] The Portuguese judges cited a study conducted by “some of the leading European and world specialists,” which was published by Oxford Academic at the end of September. It showed that if someone tested positive for Covid at a cycle threshold of 35 or higher, the chances of that person actually being infected is less than 3%, and that “the probability of… receiving a false positive is 97% or higher.”
The writer of that article, Peter Andrews, an Irish science journalist, today at RT writes an even more convincing take-down. The Corman-Drosten paper, upon which “our” entire attitude towards the PCR test is based, was written by a number of highly compromised authors, with interests in both the journal that published it, and the companies that perform the tests.
The people now criticizing the paper are a group that includes senior molecular geneticists, biochemists, immunologists, and microbiologists from Europe, the US and Japan. Not some Portuguese judges. Not that there’s anything wrong with Portuguese judges; they seem more sane to me than many other parties.
A peer review from a group of 22 international experts has found 10 “major flaws” in the main protocol for such tests. The report systematically dismantles the original study, called the Corman-Drosten paper, which described a protocol for applying the PCR technique to detecting Covid. The Corman-Drosten paper was published on January, 23, 2020, just a day after being submitted, which would make any peer review process that took place possibly the shortest in history. What is important about it is that the protocol it describes is used in around 70 percent of Covid kits worldwide. It’s cheap, fast – and absolutely useless. Among the fatal flaws that totally invalidate the PCR testing protocol are that the test:
• is non-specific, due to erroneous primer design • is enormously variable • cannot discriminate between the whole virus and viral fragments • has no positive or negative controls • has no standard operating procedure • does not seem to have been properly peer reviewed. Oh dear. One wonders whether anything at all was correct in the paper. But wait – it gets worse. As has been noted previously, no threshold for positivity was ever identified.
This is why labs have been running 40 cycles, almost guaranteeing a large number of false positives – up to 97 percent, according to some studies. The cherry on top, though, is that among the authors of the original paper themselves, at least four have severe conflicts of interest. Two of them are members of the editorial board of Eurosurveillance, the sinisterly named journal that published the paper.
And at least three of them are on the payroll of the first companies to perform PCR testing! The 22 members of the consortium that has challenged this shoddy science deserve huge credit. The scientists, from Europe, the USA, and Japan, comprise senior molecular geneticists, biochemists, immunologists, and microbiologists, with many decades of experience between them. They have issued a demand to Eurosurveillance to retract the Corman-Drosten paper, writing: “Considering the scientific and methodological blemishes presented here, we are confident that the editorial board of Eurosurveillance has no other choice but to retract the publication.’’ Talk about putting the pressure on.
It is difficult to overstate the implications of this revelation. Every single thing about the Covid orthodoxy relies on ‘case numbers’, which are largely the results of the now widespread PCR tests. If their results are essentially meaningless, then everything we are being told – and ordered to do by increasingly dictatorial governments – is likely to be incorrect. For instance, one of the authors of the review is Dr Mike Yeadon, who asserts that, in the UK, there is no ‘second wave’ and that the pandemic has been over since June. Having seen the PCR tests so unambiguously debunked, it is hard to see any evidence to the contrary.
[..] Why was this paper rushed to publication in January, despite clearly not meeting proper standards? Why did none of the checks and balances that are meant to prevent bad science dictating public policy kick into action? And why did it take so long for anyone in the scientific community to challenge its faulty methodology? These questions lead to dark ruminations, which I will save for another day.
Even more pressing is the question of what is going to be done about this now. The people responsible for writing and publishing the paper have to be held accountable. But also, all PCR testing based on the Corman-Drosten protocol should be stopped with immediate effect. All those who are so-called current ‘Covid cases’, diagnosed based on that protocol, should be told they no longer have to isolate. All present and previous Covid deaths, cases, and ‘infection rates’ should be subject to a massive retroactive inquiry.
And lockdowns, shutdowns, and other restrictions should be urgently reviewed and relaxed.
Because this latest blow to PCR testing raises the probability that we are not enduring a killer virus pandemic, but a false positive pseudo-epidemic.
And that wasn’t enough to “make my day”. Next up, we see that the newly crafted vaccines are not only potentially dangerous, at least the Pfizer and Moderna ones, they are utterly useless too. They are not designed to keep you from being infected, they merely aim to decrease the impact of the symptoms of infections. Back in September William A. Haseltine, healthcare contributor at Forbes, wrote the following.
Where was the follow-up? Why did Britain proudly announce they’ll start using the Pfizer test by next week, with other countries soon to follow? What’s going on? Why are they all spending billions on vaccines that are utterly useless -and dangerous? The vaccines don’t even pretend to stop you from getting infected, or dying. They only pretend to make you somewhat less sick once you are infected. They fight symptoms, not the infection, not the disease.
Covid-19 Vaccine Protocols Reveal That Trials Are Designed To Succeed
Moderna, Pfizer, AstraZeneca, and Johnson & Johnson are leading candidates for the completion of a Covid-19 vaccine likely to be released in the coming months. These companies have published their vaccine trial protocols. This unusually transparent action during a major drug trial deserves praise, close inspection of the protocols raises surprising concerns. These trials seem designed to prove their vaccines work, even if the measured effects are minimal. What would a normal vaccine trial look like?
Prevention of infection must be a critical endpoint. Any vaccine trial should include regular antigen testing every three days to test contagiousness to pick up early signs of infection and PCR testing once a week to confirm infection by SARS-CoV-2 test the ability of the vaccines to stave off infection. Prevention of infection is not a criterion for success for any of these vaccines. In fact, their endpoints all require confirmed infections and all those they will include in the analysis for success, the only difference being the severity of symptoms between the vaccinated and unvaccinated.
Measuring differences amongst only those infected by SARS-CoV-2 underscores the implicit conclusion that the vaccines are not expected to prevent infection, only modify symptoms of those infected. We all expect an effective vaccine to prevent serious illness if infected. Three of the vaccine protocols—Moderna, Pfizer, and AstraZeneca—do not require that their vaccine prevent serious disease only that they prevent moderate symptoms which may be as mild as cough, or headache.
[..] Vaccine efficacy is typically proved by large clinical trials over several years. The pharmaceutical companies intend to do trials ranging from thirty thousand to sixty thousand participants. This scale of study would be sufficient for testing vaccine efficacy. The first surprise found upon a closer reading of the protocols reveals that each study intends to complete interim and primary analyses that at most include 164 participants. These companies likely intend to apply for an emergency use authorization (EUA) from the Food and Drug Administration (FDA) with just their limited preliminary results.
Interim analysis success requires a 70% efficacy. The vaccine or placebo will be given to thousands of people in each trial. For Moderna, the initial interim analysis will be based on the results of infection of only 53 people. The judgment reached in interim analysis is dependent upon the difference in the number of people with symptoms, which may be mild, in the vaccinated group versus the unvaccinated group.
Moderna’s success margin is for 13 or less of those 53 to develop symptoms compared to 40 or more in their control group. For Johnson & Johnson, their interim analysis includes 77 vaccine recipients, with a success margin of 18 or less developing symptoms compared to 59 in the control group. For AstraZeneca, their interim analysis includes 50 vaccine recipients, with a success margin of 12 or less developing symptoms compared to 19 in the 25 person control group. Pfizer is even smaller in its success requirements. Their initial group includes 32 vaccine recipients, with a success margin of 7 or less developing symptoms compared to 25 in the control group.
The primary analyses are a bit more expanded, but need to be less efficacious for success: about sixty percent. AstraZeneca, Moderna, Johnson & Johnson, and Pfizer have primary analyses that distribute the vaccine to only 100, 151, 154, and 164 participants respectively. These companies state that they do not “intend” to stop trials after the primary analyses, but there is every chance that they intend to pursue an EUA and focus on manufacturing the vaccine rather than further thorough testing.
The second surprise from these protocols is how mild the requirements for contracted Covid-19 symptoms are. A careful reading reveals that the minimum qualification for a case of Covid-19 is a positive PCR test and one or two mild symptoms. These include headache, fever, cough, or mild nausea. This is far from adequate. These vaccine trials are testing to prevent common cold symptoms.
These trials certainly do not give assurance that the vaccine will protect from the serious consequences of Covid-19.Johnson & Johnson is the only trial that requires the inclusion of severe Covid-19 cases, at least 5 for the 75 participant interim analysis.
One of the more immediate questions a trial needs to answer is whether a vaccine prevents infection. If someone takes this vaccine, are they far less likely to become infected with the virus? These trials all clearly focus on eliminating symptoms of Covid-19, and not infections themselves. Asymptomatic infection is listed as a secondary objective in these trials when they should be of critical importance.
It appears that all the pharmaceutical companies assume that the vaccine will never prevent infection. Their criteria for approval is the difference in symptoms between an infected control group and an infected vaccine group. They do not measure the difference between infection and noninfection as a primary motivation.
A greater concern for the millions of older people and those with preexisting conditions is whether these trials test the vaccine’s ability to prevent severe illness and death. Again we find that severe illness and death are only secondary objectives in these trials. None list the prevention of death and hospitalization as a critically important barrier.
If total infections, hospitalizations, and death are going to be ignored in the preliminary trials of the vaccines, then there must be phase four testing to monitor their safety and efficacy. This would be long term massive scale monitoring of the vaccine. There must be an indication that the authorized vaccines are reducing infection, hospitalization, and death, or else they will not be able to stop this pandemic.
Sometimes I just don’t get this world. If you would like to argue that all of the above is false, that PCR and vaccines are all fine, and they will lift us out of this misery, hey, I’m your man, I can do with some good news. But I’m afraid we’re being played for billions.
Are our politicians and “experts” complicit or are they simply incompetent? Why don’t I leave that choice to you as well?
Source: https://www.investmentwatchblog.com
0 comments:
Post a Comment